QA: OPKO Health INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000944809_2020_OPKO_Health_INC.pdf

Logs

warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 0.9376329715361068, 'aggregate_val': 1183047000, 'exp_sum': 610563000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 343305000, 'ResearchAndDevelopmentExpense': 117870000, 'remainder_Expenses': 149388000}}
warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 1.7855733987079463, 'aggregate_val': 1395316000, 'exp_sum': 500908000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 355573000, 'ResearchAndDevelopmentExpense': 75316000, 'remainder_Expenses': 70019000}}

Graph

Absolute values for 0000944809, OPKO Health INC

  xvar xval
0 AssetsCurrent 324,045,000
1 IntangibleAssetsNetIncludingGoodwill 1,200,902,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 784,325,000
4 LiabilitiesCurrent 249,119,000
5 LiabilitiesNoncurrent 445,394,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 334,979,668
9 ResearchAndDevelopmentExpense 98,407,331
10 remainder_Expenses 719,956,501
11 remainder_Revenues 868,975,529
12 remainder_NetIncome -31,034,210
13 remainder_ComprehensiveNetIncome -9,494,148
  yvar yval
0 Assets 2,309,272,000
1 Liabilities 694,513,000
2 Expenses 1,153,343,500
3 Revenues 868,975,529
4 StockholdersEquity 1,614,759,000
5 NetIncome -315,402,181
6 ComprehensiveNetIncome -320,149,255
7 BaseVar 2,533,316,194
8 EconomicCapitalRatiobeforeLimitedLiability 2.13
9 EconomicCapitalRatio 3.11

Edgar->Model Mapping

Feature Distribution

Change over Time